Skip to main navigation Skip to search Skip to main content

Improvement in disability after alemtuzumab treatment of multiple sclerosis is associated with neuroprotective autoimmunity

  • JL Jones
  • , JA Anderson
  • , C Phuah
  • , E Fox
  • , K Selmaj
  • , D Margolin
  • , S Lake
  • , A Wilkins
  • , D Webber
  • , A Compston
  • , AJ Coles

Research output: Contribution to journalArticle (Academic Journal)peer-review

153 Citations (Scopus)
Translated title of the contributionImprovement in disability after alemtuzumab treatment of multiple sclerosis is associated with neuroprotective autoimmunity
Original languageEnglish
Pages (from-to)2232 - 2247
JournalBrain
Volume133
DOIs
Publication statusPublished - 2010

Cite this